Syra Health Corp. Reports 25% Revenue Decline and Net Loss Improvement in Q3 2025

Syra Health Corp. reported its financial results for the third quarter of 2025, revealing a net revenue of $1.69 million for the three months ending September 30, 2025, a decrease of 25% from $2.25 million in the same period of 2024. For the nine months ended September 30, 2025, the company generated $5.49 million in revenue, down from $5.98 million in the prior year. The gross profit for the quarter was $554,541, compared to $668,298 in the previous year, while the gross profit for the nine-month period increased to $1.90 million from $1.32 million, indicating a shift in cost management despite declining revenues.

The company experienced a significant increase in operating expenses, totaling $786,712 for the third quarter of 2025, down from $1.10 million in the same quarter of 2024. This reduction was primarily driven by lower salaries and benefits, which decreased from $594,738 to $336,390 year-over-year. Despite these cost reductions, Syra Health reported a net loss of $225,902 for the quarter, an improvement from a loss of $417,535 in the same quarter of the previous year. For the nine-month period, the net loss was $761,763, compared to $3.25 million in 2024, reflecting a substantial reduction in losses.

In terms of operational developments, Syra Health's customer base remains concentrated, with approximately 37% of revenues derived from the Indiana Family and Social Services Administration (FSSA) for the nine months ended September 30, 2025. The company has also seen a notable increase in accounts receivable, which rose to $926,255 from $680,827 at the end of 2024. The total liabilities increased to $1.05 million from $800,761, largely due to higher accounts payable and accrued expenses. The company’s employee headcount has not been disclosed, but the reduction in salaries suggests a strategic shift in workforce management.

Looking ahead, Syra Health Corp. has expressed concerns regarding its ability to continue as a going concern, citing a cash balance of $1.98 million and an accumulated deficit of $9.59 million. The company is actively seeking additional capital to fund its operations and has previously raised funds through convertible notes and public offerings. The management indicated that if sales do not materialize as expected, they may need to further reduce expenses or seek additional financing. The company’s future performance will depend on its ability to stabilize revenue streams and manage operational costs effectively.